Axela has introduced Panelplus Multiplex sensors and an introductory assay menu for oncology, cardiology and infectious disease research.
This assay format provides a real-time, user-configurable multiplex assays.
The kits provide the freedom to combine ready-to-use Panelplus Analytes with the researchers own targets without increasing sample consumption.
Biomarker discoveries can now be analysed with existing markers to facilitate both validation and routine analysis of new panels.
Based on optics technology, the Dotlab system uses flow-based real-time detection to deliver more information from every analysis.
Beyond quantitation of biomarker panels, additional parameters such as avidity, isotype or isoform distribution can be determined for each analyte.
Removal of endpoint assay limitations extends the measureable dynamic range and allows marker combinations not possible with existing technologies.
The integration of multiplex capability with dot technology reduces sample consumption, handling, time-to-result, and costs while generating good data quality.
The Panelplus Multiplex sensors will initially be offered for research use only on the Dotlab biomarker analysis platform.
